Bal Pharma Ltd Q3 FY2022-23 consolidated profit up at Rs. 59.16 lakhs

Bal Pharma Limited has reported Consolidated financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 77.0791 crores during the period ended December 31, 2022 as compared to Rs. 75.3553 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 0.5916 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 0.1259 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 0.38 for the period ended December 31, 2022 as compared to Rs. 0.08 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹77.0791 crs	₹75.3553 crs	2.29%
Net Profit	₹0.5916 crs	₹0.1259 crs	369.90%
EPS	₹0.38	₹0.08	375.00%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.0.5916 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.0.4753 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.0.38 for the period ended December 31, 2022 as compared to Rs.0.32 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹77.0791 crs	₹69.9191 crs	10.24%
Net Profit	₹0.5916 crs	₹0.4753 crs	24.47%
EPS	₹0.38	₹0.32	18.75%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.222.5178 crores during the 9 Months period ended December 31, 2022 as compared to Rs.145.4387 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.1.0020 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.0.4102 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.0.64 for the 9 Months period ended December 31, 2022 as compared to Rs.0.26 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹222.5178 crs	₹145.4387 crs	53.00%
Net Profit	₹1.0020 crs	₹0.4102 crs	144.27%
EPS	₹0.64	₹0.26	146.15%

Shares of Bal Pharma Limited was last trading in BSE at Rs. 82.85 as compared to the previous close of Rs. 81.65. The total number of shares traded during the day was 729 in over 51 trades.

The stock hit an intraday high of Rs. 83.15 and intraday low of 80.75. The net turnover during the day was Rs. 60327.00.

Source : Equity Bulls

Keywords

BalPharma Q3FY23 9MFY23 ResultUpdate